Tartan Zeynep, Orhan Gokcen, Kasikçioglu Hulya, Uyarel Huseyin, Unal Sennur, Ozer Nihat, Ozay Batuhan, Ciloglu Figen, Cam Nese
Department of Cardiology, Siyami Ersek Cardiovascular and Thoracic Surgery Centre, Istanbul, Turkey.
Heart Vessels. 2007 May;22(3):158-64. doi: 10.1007/s00380-006-0957-6. Epub 2007 May 21.
Increased coronary artery disease (CAD) risk is well established in diabetes mellitus (DM). Paraoxonase (PON) enzyme is known to have protective effects on lipid peroxidation. This study aimed to investigate the changes in PON activity levels with duration of DM as well as the role of PON activity in progression of CAD. Eighty-four consecutive diabetic patients (mean age 58 years, 46 men) who underwent coronary angiography for diagnostic purposes were examined. Before the angiography, fasting venous blood samples were taken for PON enzyme activity, thiobarbituric acid reactive substances (TBARS), and routine biochemical parameters. Severity and extent of coronary atherosclerosis were scored numerically using the Gensini scoring system. The population was divided into three groups according to Gensini score: Group 1, mild CAD; Group 2, moderate CAD; Group 3, severe CAD. Group 1 had higher PON levels and shorter DM duration than those of Group 3. Gensini score was significantly correlated with, PON activity (r = -0.361) and apo-AI (r = -0.375). TBARS (r = -0.290) and the duration of DM (r = -0.336) also showed a significant correlation with PON activity levels. Also, multivariate linear regression and Pearson correlation analyses showed that PON activity (P = 0.04), apo-AI levels (P = 0.01), and the duration of DM (P = 0.003) were significantly associated with Gensini score. Paraoxonase activity decreases parallel to DM duration. The lack of protective effect of PON enzyme on lipid peroxidation may be a factor in acceleration of CAD in DM.
糖尿病(DM)患者患冠状动脉疾病(CAD)的风险增加已得到充分证实。对氧磷酶(PON)已知对脂质过氧化具有保护作用。本研究旨在调查随着糖尿病病程的延长PON活性水平的变化以及PON活性在CAD进展中的作用。对84例因诊断目的接受冠状动脉造影的连续糖尿病患者(平均年龄58岁,46名男性)进行了检查。在血管造影前,采集空腹静脉血样本检测PON酶活性、硫代巴比妥酸反应性物质(TBARS)和常规生化参数。使用Gensini评分系统对冠状动脉粥样硬化的严重程度和范围进行数字评分。根据Gensini评分将人群分为三组:第1组,轻度CAD;第2组,中度CAD;第3组,重度CAD。第1组的PON水平高于第3组,且糖尿病病程短于第3组。Gensini评分与PON活性(r = -0.361)和载脂蛋白A-I(r = -0.375)显著相关。TBARS(r = -0.290)和糖尿病病程(r = -0.336)也与PON活性水平显著相关。此外,多变量线性回归和Pearson相关分析表明,PON活性(P = 0.04)、载脂蛋白A-I水平(P = 0.01)和糖尿病病程(P = 0.003)与Gensini评分显著相关。对氧磷酶活性随糖尿病病程平行下降。PON酶对脂质过氧化缺乏保护作用可能是糖尿病患者CAD加速发展的一个因素。